Skip to main content

Table 3 Characterization of PHBV-PTX-NPs, PDA-PHBV-PTX-NPs and RGD-PDA-PHBV-PTX-NPs

From: pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma

Samples (n = 3) Size (nm) PDI LE (%) EE (%)
PHBV-PTX-NPs 66.7 ± 5.2 0.142 21.48 ± 0.83 74.42 ± 1.21
PDA-PHBV-PTX-NPs 113.5 ± 7.4 0.153 15.33 ± 0.74 73.45 ± 1.03
RGD-PDA-PHBV-PTX-NPs 124.6 ± 7.7 0.163 14.21 ± 0.66 71.21 ± 1.06
  1. Data presents as mean ± standard deviation
  2. PDI polydispersion index, LE drug loading efficiency, EE encapsulation efficiency